Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in CRON — Cronos Group Inc.

CIK 1423053 MIAMI, FL
Back to CRON Full portfolio

Position in CRON

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$2,643,737
+$1,728,449 QoQ
Shares Held
950,985
+160.8% QoQ
Ownership
0.258%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 192 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRON Over Time

Shares Held

Position Value (USD)

Derivatives in CRON

reported options exposure · as of Jun 30, 2026
CallValue
$631,060
CallShares
227,000
PutValue
$278,834
PutShares
100,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,675,844 across 65 Drug Manufacturers - Specialty & Generic names. CRON ranks #25 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in CRON

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $631,060 227,000
2026-06-30 $278,834 100,300
2026-06-30 $2,643,737 950,985
2026-03-31 $915,288 364,657
2026-03-31 $820,268 326,800
2026-03-31 $412,142 164,200
2025-12-31 $4,651,683 1,768,701
2025-12-31 $1,183,763 450,100
2025-12-31 $834,499 317,300
2025-09-30 $352,504 126,800
2025-09-30 $4,471,218 1,608,352
2025-09-30 $501,234 180,300
2025-06-30 $116,510 61,000
2025-06-30 $269,310 141,000
2025-06-30 $1,253,372 656,216
2025-03-31 $131,988 72,922
2025-03-31 $215,390 119,000
2025-03-31 $268,423 148,300
2024-12-31 $462,176 228,800
2024-12-31 $983,066 486,667
2024-12-31 $403,798 199,900
2024-09-30 $366,606 167,400
2024-09-30 $319,740 146,000
2024-09-30 $1,120,736 511,752
2024-06-30 $580,869 249,300
2024-06-30 $2,647,672 1,136,340
2024-06-30 $370,936 159,200
2024-03-31 $623,268 238,800
2024-03-31 $3,001,569 1,150,027
2024-03-31 $1,103,247 422,700
2023-12-31 $947,815 453,500
2023-12-31 $1,354,443 648,059
2023-12-31 $319,143 152,700
2023-09-30 $673,800 336,900
2023-09-30 $336,200 168,100
2023-09-30 $569,038 284,519
2023-06-30 $436,355 221,500
2023-06-30 $30,304 15,383
2023-06-30 $543,326 275,800
2023-03-31 $1,377,594 710,100
2023-03-31 $1,234,066 636,117
2023-03-31 $751,362 387,300
2022-12-31 $2,637,282 1,038,300
2022-12-31 $3,180,080 1,252,000
2022-12-31 $2,196,019 864,575
2022-09-30 $1,290,045 457,463
2022-09-30 $2,997,378 1,062,900
2022-09-30 $938,214 332,700
2022-06-30 $2,443,530 866,500
2022-06-30 $748,763 265,519